Meditransfer Centrum Transferu Technologii Iitdsp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-06-09
Share capital
286 000,00 PLN
Activity description

The Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences conducts research in clinical immunology, experimental cancer therapy, glycoimmunology, infection immunology and immunopharmacology. It also works on bacteriophages and phage therapy, molecular microbiology, virology, molecular biology, biochemistry and biotechnology. The institute can award doctoral and habilitation degrees in biological and medical sciences.

Registered address
Weigla 12/125, 53-114 Wrocław, Poland
Website
iitd.pan.wroc.plWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-14588-70473-RAJRH-32

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 35.49kMedianUSD 126.89kAverageUSD 4.67m
Net profit
This companyUSD -186.19kMedianUSD -19.64AverageUSD 371.62k
Operating costs
This companyUSD 221.41kMedianUSD 165.83kAverageUSD 4.01m
Assets
This companyUSD 2.13mMedianUSD 251.40kAverageUSD 7.40m

Bank accounts

Registered as a VAT taxpayer on 2023-04-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant datePurposeGross amountGranting body
Oct 23, 2023
Aid for research and development projects: experimental development
—Prezes Agencji Badań Medycznych
Oct 23, 2023
Aid for research and development projects: industrial research
—Prezes Agencji Badań Medycznych

Tenders

2 tenders recorded as contractor, with a total value of $381,710.

Publication dateSubjectAmountContracting authority
Feb 24, 2026
Wykonanie systemu do laboratorium genetycznego wraz z narzędziami analitycznymi
$215,964Instytut Immunologii I Terapii Doświadczalnej Im.Ludwika Hirszfelda Pan we Wrocławiu
Jul 15, 2025
Usługa zarządzania procesami rozwoju i komercjalizacji innowacji
$165,746Instytut Immunologii I Terapii Doświadczalnej Im.Ludwika Hirszfelda Pan we Wrocławiu

Authorized Representatives

Tomasz Węsierski — Management Board Member

Manner of representation

If the management board is multi-member, each member of the management board is authorised independently to make declarations of will on behalf of the company.

Supervisory board

Małgorzata Krynicka Duszyńska — Supervisory Board Member
Jacek Rybka — Supervisory Board Member
Łukasz Łaczmański — Supervisory Board Member
Radosław Pioterczak — Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Instytut Immunologii I Terapi Doświadczalnej Im. Ludwika Hirszfelda Polskiej Akademii Nauk We Wrocławiu
10$135.060.1748%
Others
5,710$77,120.4899.8252%

Beneficial owners

PersonRights
Piotr Adamiec (50)
Z-ca dyrektora w przedsiębiorstwie posiadającym 100% udziałów w spółce
Andrzej Wincenty Gamian (75)
Reprezentuje właściciela jako dyrektor przedsiębiorstwa posiadającego 100% udziałów w spółce
Jolanta Katarzyna Łukasiewicz (54)
Z-ca dyrektora w przedsiębiorstwie posiadającym 100% udziałów w spółce
Swen Tadeusz Stręk (46)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Tomasz Węsierski (52)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

Selected automatically: mainly by similarity of the business description, plus comparable revenue, industry (PKD code) and location. Only companies with a complete profile (including a logo and financial data) are shown. The list is indicative.

Change history

DateEvent
2026-09-23Name change (Centrum Transferu Technologii Meditransfer Iitd → Meditransfer Centrum Transferu Technologii Iitd)
2026-09-23Share capital change (276,000.00 PLN → 286,000.00 PLN)
2022-09-23Name change (Centrum Transferu Technologii Iitd → Centrum Transferu Technologii Meditransfer Iitd)
2022-09-23PKD change (Added: 72.11.Z, 72.19.Z, 82.30, 85.60.Z)
2018-09-05Share capital change (274,000.00 PLN → 276,000.00 PLN)

FAQ

Last updated: 2026-10-02